Wellington Grp »

Intellia Therapeutics shares owned by Wellington Grp

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Wellington Grp from 13F filings

Historical chart of Wellington Grp investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Wellington Grp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Wellington Grp

Quarter filed Position value Share count Share price at filing
2026-03-31 $594k 46k 12.82
2025-12-31 $276k 31k 8.99

More positions owned by Wellington Grp

Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Exch Traded Fd Tr Ii S&p Smallcap 600 (RWJ)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Ishares Tr Ultra Short Dur (ICSH)
Ishares Tr TRS FLT RT BD (TFLO)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Eli Lilly & Co. (LLY)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Spdr Series Trust State Street Spd (SPSB)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)

View all positions for Wellington Grp

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
D. E. Shaw & Co
Vanguard Capital Management
Two Sigma Investments
Regeneron Pharmaceuticals
UBS Group
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Intellia Therapeutics